Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Power Doppler Imaging of Prostate Cancer

  • Chapter
  • First Online:
Image Guided Prostate Cancer Treatments

  • 1832 Accesses

Abstract

Prostatic tumors range from small slow-growing lesions to aggressive tumors that metastasize rapidly, and there is controversy about which screen-detected lesion will become clinically significant (Neal and Donovan 2000). Current methods of screening involve measurement of PSA followed by transrectal ultrasound scanning and biopsy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aarninck RG, Beerlage HP, De La Rosette JJ, Debruyne FM, Wijkstra A. Transrectal ultrasound of the prostate: innovations and future applications. J Urol. 1998;159:1568–79.

    Article  Google Scholar 

  • Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005;293:2095–101.

    Article  PubMed  CAS  Google Scholar 

  • Bree RL. The role of color Doppler and staging biopsies in prostate cancer detection. Urology. 1997;49:31–4.

    Article  PubMed  CAS  Google Scholar 

  • Cornud F, Belin X, Piron D, Chrétien Y, Flam T, Casanova JM, et al. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology. 1997;49(5):709–15.

    Article  PubMed  CAS  Google Scholar 

  • Cornud F, Hamida K, Flam T, Hélénon O, Chrétien Y, Thiounn N, et al. Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. AJR Am J Roentgenol. 2000;175(4):1161–8.

    Article  PubMed  CAS  Google Scholar 

  • D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969–74.

    Article  PubMed  Google Scholar 

  • D’Amico AV, Chen MH, Roehl KA, Catalona WJ. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med. 2004;351:125–35.

    Article  PubMed  Google Scholar 

  • Dall’Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer. 2008;112(12):2664–70.

    Article  PubMed  Google Scholar 

  • Halpern EJ, Strup SE. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR. 2000;174:623–7.

    Article  PubMed  CAS  Google Scholar 

  • Hara N, Kasahara T, Kawasaki T, Bilim V, Tomita Y, Obara K, Takahachi K. Frequency of PSA-mRNA- bearing cells in the peripheral blood of patients after prostate biopsy. Br J Cancer. 2001;85(4):557–62.

    Article  PubMed  CAS  Google Scholar 

  • Kelly I, Lees W, Rickards D. Prostate cancer and the role of color Doppler US. Radiology. 1993;189:153–6.

    PubMed  CAS  Google Scholar 

  • Kuligowska E, Barish MA, Fenlon HM, Blake MA. Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers. Radiology. 2001;220:757–64.

    Article  PubMed  CAS  Google Scholar 

  • Lavoipierre AM, Snow RM, Frydenberg M, Gunter D, Reisner G, Royce PL, Lavoipierre GL. Prostatic cancer: role of color Doppler imaging in transrectal sonography. AJR. 1998;171(1):205–10.

    Article  PubMed  CAS  Google Scholar 

  • Neal DE, Donovan JL. Prostate cancer: to screen or not to screen? Lancet Oncol. 2000;1(1):17–24.

    Article  PubMed  CAS  Google Scholar 

  • Newmann JS, Bree RL, Rubin JM. Prostate cancer: diagnosis with color Doppler sonography with histological correlation of each biopsy site. Radiology. 1995;195(1):86–90.

    Google Scholar 

  • Resnick NI, Willard JW, Boyce WH. Ultrasonic evaluation of the prostatic nodule. J Urol. 1981;120:86–9.

    Google Scholar 

  • Rifkin M, Sudakoff G, Alexander A. Prostate: techniques, results and potential applications of color Doppler US scanning. Radiology. 1993;186:509–13.

    PubMed  CAS  Google Scholar 

  • Sauvain JL, Palascak P, Bremon JM. Power Doppler ultrasonography and hypoechoic nodules of peripheral prostate: prospective and limitations. J Radiol. 1997;78:491–7.

    PubMed  CAS  Google Scholar 

  • Sauvain JL, Palascak P, Bourscheid D, Chabi C, Atassi A, Bremon JM, et al. Value of power doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer. Eur Urol. 2003;44(1):21–30.

    Article  PubMed  CAS  Google Scholar 

  • Sauvain JL, Palascak P, Nader N, Gomez W, Bloqueau P, Bremon JM, et al. Echo-Doppler et cancer de la prostate: option ou nécessité? J Radiol. 2006;87(9):1063–72.

    Article  PubMed  CAS  Google Scholar 

  • Sauvain JL, Sauvain E, Rohmer P, Louis D, Nader N, Papavero R, Bremon JM, Jehl J. Value of transrectal power Doppler sonography in the detection of low-risk prostate cancers. Diagnostic and Interventional Imaging. 2013;94:60–7.

    Article  PubMed  Google Scholar 

  • Stoica G, Cariou G, Colau A, Cortesse A, Hoffmann P, Schaetz A, Sellam R. Epidemiology and treatment of acute prostatitis after prostatic biopsy. Prog Urol. 2007;17(5):960–3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Imaging Medical Center, 6 passage Jules Didier, 70000, Vesoul, France

    Jean-Luc Sauvain MD

Authors
  1. Jean-Luc Sauvain MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-Luc Sauvain MD .

Editor information

Editors and Affiliations

  1. Biofoundation for angiogenesis Research and Development, Bard Cancer Center, New York, New York, USA

    Robert L. Bard

  2. Department of Radiology, Radboud University Medical Centre, HB Nijmegen, The Netherlands

    Jurgen J. Fütterer

  3. Sperling Prostate Center, Carlstadt, New Jersey, USA

    Dan Sperling

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sauvain, JL. (2014). Power Doppler Imaging of Prostate Cancer. In: Bard, R., Fütterer, J., Sperling, D. (eds) Image Guided Prostate Cancer Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40429-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-40429-0_5

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-40428-3

  • Online ISBN: 978-3-642-40429-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation